Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-23T02:15:56.170Z Has data issue: false hasContentIssue false

Delirium associated with sertraline, a case report

Published online by Cambridge University Press:  23 March 2020

N. Salgado*
Affiliation:
Hospital Dr. Rodriguez Lafora, Psiquiatria, Madrid, Spain
S. Benavente
Affiliation:
Hospital Universitario 12 de Octubre, psiquiatria, Madrid, Spain
B. Macias
Affiliation:
Hospital Dr. Rodriguez Lafora, Psiquiatria, Madrid, Spain
M. Duran
Affiliation:
Hospital Dr. Rodriguez Lafora, Psiquiatria, Madrid, Spain
P. Leganes
Affiliation:
Hospital Dr. Rodriguez Lafora, Psiquiatria, Madrid, Spain
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Delirium is a clinical entity consisting of acute loss of consciousness, with attention deficit and fluctuating evolution. Antidepressive medication can cause these symptoms or worsen them.

Case report

We report the case of a 84-year-old blind female who was diagnosed of delirium in relation to intoxication with sertraline. The patient was admitted into a short-stay psychiatric unit for three days. She presented behavioural disturbances consisting in auto and heteroaggressive behaviour, altered consciousness and visual hallucinations (rocks, turtles). When dosage of sertraline was doubled from 50 mg/day to 100 mg/day visual hallucinations started. There were not other medical causes found, so sertraline was suspended, achieving clinical improvement.

Discussion

This case report shows how a patient with antidepressive treatment can display delirium. The three main causes of delirium that are infections, side effects and methabolic syndrome.

Conclusions

In the case of treating a patient with delirium, the presence of previous illness has to be investigated. It is indispensable to describe the presence of previous illness, medication and recent changes of the dosages in the medical history in a patient with Sertraline.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV1331
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.